These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 37044053)

  • 1. Lipophagy-related gene RAB7A is involved in immune regulation and malignant progression in hepatocellular carcinoma.
    Liu Y; Ma J; Wang X; Liu P; Cai C; Han Y; Zeng S; Feng Z; Shen H
    Comput Biol Med; 2023 May; 158():106862. PubMed ID: 37044053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of NDRG1 leads to poor prognosis in hepatocellular carcinoma through mediating immune infiltration and EMT.
    Wang X; Sun R; Che N; Zhang D; Li Y; Zhao N
    Dig Liver Dis; 2024 Aug; 56(8):1382-1399. PubMed ID: 38290958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
    Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
    Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
    Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA
    Gong X; Zhu Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
    [No Abstract]   [Full Text] [Related]  

  • 8. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
    Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
    DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Biological Function of POLA2 in Hepatocellular Carcinoma.
    Yang Z; Shen X; Wang Z; Li R; Hou W; Liu Z; Gao Y; Zhu C; Qin X
    Comb Chem High Throughput Screen; 2024; 27(12):1758-1775. PubMed ID: 37861044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
    Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
    J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B4GALNT1 promotes carcinogenesis by regulating epithelial-mesenchymal transition in hepatocellular carcinoma based on pan-cancer analysis.
    Liu W; Chen Y; Yang J; Guo M; Wang L
    J Gene Med; 2023 Nov; 25(11):e3552. PubMed ID: 37337736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of the tumor-promoting effect and immune infiltration correlation MAZ from pan-cancer to hepatocellular carcinoma.
    Wang M; Yang X; Meng Y; Jin Z; Cao J; Xiong L; Xiong Z
    Int Immunopharmacol; 2023 Feb; 115():109660. PubMed ID: 36623412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma.
    Huang W; Yu D; Wang M; Han Y; Lin J; Wei D; Cai J; Li B; Chen P; Zhang X
    Cell Prolif; 2020 Jul; 53(7):e12836. PubMed ID: 32537856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.